PARSIPPANY, N.J., Feb. 8, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has reached a ...

Pharma firm Lupin Ltd today said it has received US health regulator's approval to sell generic version of oral contraceptive, Ortho Tri-cyclen Lo tablets in the American market. Advisory Alert: It ...

Watson Pharmaceuticals Inc. said Wednesday it settled a patent lawsuit brought by a unit of Johnson & Johnson over a generic version of the birth control drug Ortho Tri-Cyclen Lo. Watson said it will ...

Jerusalem, Israel, July 17, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that further to its press release dated July 7, 2009, the Company and Ortho McNeil Janssen have ...

Lupin Pharmaceuticals announced that it has received FDA approval for Norgestimate and Ethinyl Estradiol Tablets, the generic version of Janssen‘s Ortho Tri-Cyclen Lo tablets. Ortho Tri-Cyclen Lo is a ...

BSE : 500257 NSE: Lupin REUTERS: LUPN.BO BLOOMBERG: LPC IN Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for its ...

May 15, 2006 (Washington) — Despite reports the contrary, norgestimate/ethinyl estradiol (Ortho Tri-Cyclen Lo) is not associated with an increased risk of pregnancy in overweight or obese women, ...

Johnson & Johnson filed suit against Watson Pharmaceuticals Inc., alleging infringement of its Ortho Tri-Cyclen LO birth-control pill. Corona-based Watson submitted an application with the Food and ...

Shares of pharma major Lupin fell 3.3% after reports of a New Jersey US district court upholding the patent held by a unit of Johnson & Johnson's for a oral contraceptive (OC) drug Ortho Tri-Cyclen Lo ...

Mumbai, Baltimore, January 06, 2016: Pharma Major Lupin Limited (Lupin) announced that its US subsidiary Lupin Pharmaceutical Inc. has launched its Tri-Lo-Marzia™ Tablets (Norgestimate and Ethinyl ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that further to its press release dated July 1, 2009, Teva and Ortho McNeil Janssen have agreed to cease ...

Mylan Launches Generic Xeloda Mylan announced the launch of Norgestimate and Ethinyl Estradiol Tablets, 0.18mg/0.025mg, 0.215mg/0.025mg, and 0.25mg/0.025mg, the generic version of Janssen's Ortho ...